Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2016 Sep 17

PMID 27634385

Citations 32

Authors

Hui-Yuan Zhai

Ming-Hua Sui

Xiao Yu

Zhen Qu

Jin-Chen Hu

Hai-Qing Sun

Hai-Tao Zheng

Kai Zhou

Li-Xin Jiang

Affiliations

Soon will be listed here.

Abstract

BACKGROUND Colon cancer is one of the most prevalent and deadly cancers worldwide. It is still necessary to further define the mechanisms and explore therapeutic targets of colon cancer. Dysregulation of long noncoding RNAs (lncRNAs) has been shown to be correlated with diverse biological processes, including tumorigenesis. This study aimed to characterize the biological mechanism of taurine-upregulated gene 1 (TUG1) in colon cancer. MATERIAL AND METHODS qRT-PCR was used to analyze the expression level of TUG1 and p63 in 75 colon cancer tissues and the matched adjacent non-tumor tissue. In vitro, cultured colon cancer cell lines HCT-116 and LoVo were used as cell models. TUG1 and p63 were silenced via transferring siRNA into HCT-116 or LoVo. The effects of TUG1 were investigated by examining cell proliferation, apoptosis, and migration. RESULTS Among the 75 colon cancer cases, the expression of TUG1 was significantly higher in colon cancer tissues compared with the matched adjacent non-tumor tissue, while p63 expression was lower in the tumor tissue. In HCT-116 and LoVo, the expression of TUG1 was significantly increased by p63 siRNA transfection. Furthermore, down-regulation of TUG1 by siRNA significantly inhibited the cell proliferation and promoted colon cancer cell apoptosis. In addition, inhibition of TUG1 expression significantly blocked the cell migration ability of colon cancer cells. CONCLUSIONS LncRNA TUG1 may serve as a potential oncogene for colon cancer. Overexpressed TUG1 may contribute to promoting cell proliferation and migration in colon cancer cells.

Citing Articles

The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cells.

Hillman T Front Oncol. 2023; 13:1194350.

PMID: 37388221 PMC: 10301836. DOI: 10.3389/fonc.2023.1194350.

The pathogenic roles of lncRNA-Taurine upregulated 1 (TUG1) in colorectal cancer.

Azizidoost S, Nasrolahi A, Ghaedrahmati F, Kempisty B, Mozdziak P, Radoszkiewicz K Cancer Cell Int. 2022; 22(1):335.

PMID: 36333703 PMC: 9636703. DOI: 10.1186/s12935-022-02745-1.

SP1-mediated up-regulation of lncRNA TUG1 underlines an oncogenic property in colorectal cancer.

Liu W, Meng J, Su R, Shen C, Zhang S, Zhao Y Cell Death Dis. 2022; 13(5):433.

PMID: 35508523 PMC: 9068916. DOI: 10.1038/s41419-022-04805-w.

Serum-Based lncRNA ANRIL, TUG1, UCA1, and HIT Expressions in Breast Cancer Patients.

Alkhathami A, Hadi A, Alfaifi M, Yahya Alshahrani M, Verma A, Ali Beg M Dis Markers. 2022; 2022:9997212.

PMID: 35132340 PMC: 8817891. DOI: 10.1155/2022/9997212.

BiGAN: LncRNA-disease association prediction based on bidirectional generative adversarial network.

Yang Q, Li X BMC Bioinformatics. 2021; 22(1):357.

PMID: 34193046 PMC: 8247109. DOI: 10.1186/s12859-021-04273-7.

References

Wu Z, Wang X, Tang H, Jiang T, Chen J, Lu S . Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. Oncol Rep. 2014; 32(1):395-402. DOI: 10.3892/or.2014.3186. View

Wang H, Lu J, Chen W, Gu A . Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. Int J Clin Exp Med. 2015; 8(7):11824-30. PMC: 4565407. View

Pathak S, Meng W, Kumar Nandy S, Ping J, Bisgin A, Helmfors L . Radiation and SN38 treatments modulate the expression of microRNAs, cytokines and chemokines in colon cancer cells in a p53-directed manner. Oncotarget. 2015; 6(42):44758-80. PMC: 4792590. DOI: 10.18632/oncotarget.5815. View

He X, Tan X, Wang X, Jin H, Liu L, Ma L . C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion. Tumour Biol. 2014; 35(12):12181-8. DOI: 10.1007/s13277-014-2526-4. View

Zeng C, Yu X, Lai J, Yang L, Chen S, Li Y . Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol. 2015; 8:126. PMC: 4636781. DOI: 10.1186/s13045-015-0223-4. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

Hu Y, Pan C, Hu J, Zhang S . The role of Reg IV in colorectal cancer, as a potential therapeutic target. Contemp Oncol (Pozn). 2015; 19(4):261-4. PMC: 4631303. DOI: 10.5114/wo.2015.54385. View

Wong H, Chang W . Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers. Oncotarget. 2015; 6(39):42169-82. PMC: 4747217. DOI: 10.18632/oncotarget.5888. View

Han Y, Liu Y, Gui Y, Cai Z . Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder. J Surg Oncol. 2012; 107(5):555-9. DOI: 10.1002/jso.23264. View

10.

Thorenoor N, Faltejskova-Vychytilova P, Hombach S, Mlcochova J, Kretz M, Svoboda M . Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget. 2015; 7(1):622-37. PMC: 4808022. DOI: 10.18632/oncotarget.5807. View

11.

Zhou J, Zhi X, Wang L, Wang W, Li Z, Tang J . Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. J Exp Clin Cancer Res. 2015; 34:135. PMC: 4632266. DOI: 10.1186/s13046-015-0250-6. View

12.

Gavriilidis P, Nikolaidou A . Colon Adenocarcinoma Associated with Synchronous Extramural Gastrointestinal Stromal Tumor (GIST) of the Ileum. Am J Case Rep. 2015; 16:837-9. PMC: 4671400. DOI: 10.12659/ajcr.894845. View

13.

van Heesch S, van Iterson M, Jacobi J, Boymans S, Essers P, de Bruijn E . Extensive localization of long noncoding RNAs to the cytosol and mono- and polyribosomal complexes. Genome Biol. 2014; 15(1):R6. PMC: 4053777. DOI: 10.1186/gb-2014-15-1-r6. View

14.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

15.

Zhang Q, Geng P, Yin P, Wang X, Jia J, Yao J . Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis. Asian Pac J Cancer Prev. 2013; 14(4):2311-5. DOI: 10.7314/apjcp.2013.14.4.2311. View

16.

Yue B, Qiu S, Zhao S, Liu C, Zhang D, Yu F . LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis. J Gastroenterol Hepatol. 2015; 31(3):595-603. DOI: 10.1111/jgh.13206. View

17.

Tsai C, Wu M . Frequent Ischemic Stroke as First Manifestation of Occult Colon Cancer: A Rare Case. Am J Case Rep. 2015; 16:723-7. PMC: 4610689. DOI: 10.12659/ajcr.895130. View

18.

Huang M, Chen W, Qi F, Sun M, Xu T, Ma P . Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Mol Cancer. 2015; 14:165. PMC: 4558931. DOI: 10.1186/s12943-015-0431-0. View

19.

Cedermark B, Dahlberg M, Glimelius B, Pahlman L, Rutqvist L, Wilking N . Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997; 336(14):980-7. DOI: 10.1056/NEJM199704033361402. View

20.

Gonfloni S, Caputo V, Iannizzotto V . P63 in health and cancer. Int J Dev Biol. 2015; 59(1-3):87-93. DOI: 10.1387/ijdb.150045sg. View